Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Non Operating Income (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 6 years of Non Operating Income data on record, last reported at -$43000.0 in Q4 2025.

  • For Q4 2025, Non Operating Income fell 200.0% year-over-year to -$43000.0; the TTM value through Dec 2025 reached -$4.2 million, down 77.36%, while the annual FY2025 figure was -$4.2 million, 77.36% down from the prior year.
  • Non Operating Income reached -$43000.0 in Q4 2025 per MRVI's latest filing, up from -$71000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $914000.0 in Q4 2022 and bottomed at -$4.1 million in Q2 2025.
  • Average Non Operating Income over 5 years is -$395450.0, with a median of $15500.0 recorded in 2022.
  • Peak YoY movement for Non Operating Income: plummeted 42400.0% in 2022, then soared 2300.0% in 2023.
  • A 5-year view of Non Operating Income shows it stood at $201000.0 in 2021, then skyrocketed by 354.73% to $914000.0 in 2022, then tumbled by 94.64% to $49000.0 in 2023, then fell by 12.24% to $43000.0 in 2024, then plummeted by 200.0% to -$43000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were -$43000.0 in Q4 2025, -$71000.0 in Q3 2025, and -$4.1 million in Q2 2025.